CROI 2015 Program and Abstracts

Poster Listings

TUESDAY, FEBRUARY 24, 2015 Session P-O1 Poster Session

WEDNESDAY, FEBRUARY 25, 2015 Session P-O2 Poster Session

Poster Hall

Poster Hall

2:30 pm– 4:00 pm HPV Infections and Cancers 710 Factors AssociatedWith Extensive Cervical Lesions Among HIV-Infected Women Screening for AIDS Clinical Trials Group (ACTG) Protocol A5282 Timothy J. Wilkin 1 ; Roy Matining 2 ;Vikrant Sahasrabuddhe 3 ; Catherine Godfrey 4 ;Thandie Lungu 5 ; Mulindi Mwanahamuntu 6 ; Ramesh Bhosale 7 ; Scott Evans 2 ; RobertW. Coombs 8 ; Cynthia Firnhaber 9 1 Weill Cornell Medical College, New York, NY, US; 2 Harvard School of Public Health, Center for Biostatistics in AIDS Research, Cambridge, MA, US; 3 National Cancer Institute (NCI), Bethesda, MD, US; 4 Division of AIDS (DAIDS), NIAID, NIH, Bethesda, MD, US; 5 University of North Carolina Project–Malawi, Lilongwe, Malawi; 6 University Teaching Hospital, Lusaka, Zambia; 7 Byramjee Jeejeebhoy Medical College, Pune, India; 8 University of Washington, Seattle, WA, US; 9 University of Witswatersand, Johannesburg, South Africa 711 HIV Infection and Survival AmongWomenWith Cervical Cancer in Botswana Scott Dryden-Peterson 1 ; Memory Bvochora-Nsingo 2 ; Heluf Medhin 3 ; Gita Suneja 4 ; Aida Asmelash 5 ; Malebogo Pusoentsi 3 ; Anthony Russell 6 ; Jason Efstathiou 6 ; Bruce Chabner 6 ; Shahin Lockman 1 1 Brigham and Women’s Hospital, Harvard Medical School, Jamaica Plain, MA, US; 2 Gaborone Private Hospital, Gaborone, Botswana; 3 Botswana Ministry of Health, Gaborone, Botswana; 4 University of Utah, Salt Lake City, UT, US; 5 Botswana Harvard AIDS Institute, Gaborone, Botswana; 6 Massachusetts General Hospital, Harvard Medical School, Boston, MA, US 712 Potential Cost-Effectiveness of Cervical Cancer Screening of HIV-Positive KenyanWomen Marita Mann ; Joseph Babigumira; Louis Garrison; Michael Chung University of Washington, Seattle, WA, US 713 Anal High-Risk Human Papillomavirus (HPV) Infection Among HIV- Infected MSM in the SUN Study, 2004-2011 Pragna Patel 1 ;Tim Bush 1 ; Erna Kojic 2 ; Lois Conley 1 ; Elizabeth Unger 1 ;Teresa Darragh 3 ; Keith Henry 4 ; John Hammer 5 ; Nur Onen 6 ; Joel Palefsky 3 1 CDC, Atlanta, GA, US; 2 Brown University, Providence, RI, US; 3 University of California San Francisco, San Francisco, CA, US; 4 University of Minnesota, Minneapolis, MN, US; 5 Denver Infectious Diseases Consultants, Denver, CO, US; 6 Washington University School of Medicine, St. Louis, MO, US 714 Long-Term Effectiveness of Electrocautery Ablation of HGAIN in HIV- Infected MSM Joaquin Burgos 1 ; Adria Curran 1 ; NataliaTallada 1 ; Ana Guelar 2 ; Jordi Navarro 1 ; Stefania Landolfi 1 ; JudithVillar 2 ; Manel Crespo 1 ; Esteve Ribera 1 ;Vicenç Falco 1 1 University Hospital Vall d’Hebron, Barcelona, Spain; 2 University Hospital del Mar, Barcelona, Spain 715 Survival and Treatment Trends for Squamous Cell Carcinoma of the Anus in HIV Infection Robert A. Pitts ; Stephen Goldstone; Keith Sigel; Michael M. Gaisa; Carlie Sigel; Juan Wisnivesky Icahn School of Medicine at Mount Sinai, New York, NY, US 716 Oral HPV Shedding andWarts After Starting Antiretroviral Therapy: ACTG Protocol A5272 Caroline H. Shiboski 1 ; Anthony Lee 2 ; JenniferWebster-Cyriaque 3 ; Huichao Chen 2 ; Malcolm John 1 ; Raphael J. Landovitz 4 ; Mark Jacobson 1 Oral HIV/AIDS Research Alliance and the AIDS ClinicalTrial Group 1 University of California San Francisco, San Francisco, CA, US; 2 Harvard School of Public Health, Center for Biostatistics in AIDS Research, Boston, MA, US; 3 University of North Carolina, Chapel Hill, NC, US; 4 University of California Los Angeles, Los Angeles, CA, US 717 Excess Risk of Rectal Squamous Cell Carcinoma in HIV-Infected Persons Anna E. Coghill ; Meredith S. Shiels; Eric A. Engels National Cancer Institute, Rockville, MD, US

2:30 pm– 4:00 pm AIDS-Related Cancers: Lymphoma and KS 718 Incidence and Outcomes of HIV-Associated Lymphomas in Botswana Michael G. Milligan 1 ; Elizabeth Bigger 3 ; Musimar Zola 7 ; Mukendi Kayembe 6 ; Heluf Medhin 5 ; Gita Suneja 4 ; Shahin Lockman 2 ; Jeremy Abramson 3 ; Bruce Chabner 3 ; Scott Dryden- Peterson 2 1 Harvard Medical School, Brookline, MA, US; 2 Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, US; 3 Massachusetts General Hospital, Harvard Medical School, Boston, MA, US; 4 University of Utah, Salt Lake City, UT, US; 5 Botswana Ministry of Health, Gaborone, Botswana; 6 Botswana National Health Laboratory, Gaborone, Botswana; 7 Princess Marina Hospital, Gaborone, Botswana 719 CHOP Is Feasible for HIV-Associated Lymphoma in the ART Era in Malawi Satish Gopal 2 ;Yuri Fedoriw 1 ; Agnes Moses 2 ; Nathan Montgomery 1 ;Wongani Kaimila 2 ; Coxcilly Kampani 2 ; Robert Krysiak 2 ; Kristy Richards 1 ;Thomas Shea 1 ; George Liomba 2 1 University of North Carolina, Chapel Hill, NC, US; 2 University of North Carolina Project–Malawi, Lilongwe, Malawi 720 Chronic Hepatitis B and C Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients Heiner C. Bucher On behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord University Hospital Basel, Basel, Switzerland 721 HIV-Associated Kaposi Sarcoma TreatedWith Chemotherapy and ART in Rural Malawi Michael E. Herce 1 ; Noel Kalanga 2 ; JonathanT. Crocker 2 ; Emily B.Wroe 2 ; JamesW. Keck 2 ; Felix D. Chingoli 3 ; Satish Gopal 1 ; Junior Bazile 2 ; Jason A. Beste 2 ; Jonas Rigodon 2 1 University of North Carolina, Chapel Hill, NC, US; 2 Partners In Health, Neno, Malawi; 3 Ministry of Health of the Republic of Malawi, Neno, Malawi 722 High Mobility Group Box 1 (HMGB1) and HIV-Associated Kaposi Sarcoma in Africa Helen Byakwaga 1 ; PeterW. Hunt 3 ; Miriam O. Laker-Oketta 2 ; Albert R. Davalos 6 ; Conrad Muzoora 1 ; DavidV. Glidden 3 ; A. Rain Mocello 3 ; David R. Bangsberg 4 ; Edward Mbidde 5 ; Jeffrey N. Martin 3 1 Mbarara University of Science and Technology, Mbarara, Uganda; 2 Infectious Diseases Institute, Kampala, Uganda; 3 University of California San Francisco, San Francisco, CA, US; 4 Massachusetts General Hospital, Center for Global Health, Harvard Medical School, Boston, MA, US; 5 Uganda Virus Research Institute, Entebbe, Uganda; 6 Buck Institute for Research on Aging, Novato, CA, US 723 The CXCL12/CXCR4-CXCR7 Pathway, a Trio Implicated in Kaposi Sarcoma Pathogenesis Aude Desnoyer 2 ; Francoise Gaudin 2 ; Agnes Carlotti 3 ; Nicolas Dupin 3 ; Francois Boue 2 ; Karl Balabanian 2 ; Valérie Martinez-Pourcher 1 1 Hopital Pitié-Salpêtrière, Paris, France; 2 Inserm, Univ Paris-Sud, LABEX LERMIT, UMR_S996, Clamart, France; 3 Dermatology, Paris, France 2:30 pm– 4:00 pm Cancer and Cancer Risk in HIV Subpopulations and Lung Cancer 724 Cancer in HIV-Infected Children: Record Linkage Study in South Africa Julia Bohlius 6 ; Nicky Maxwell 2 ; Brian Eley 3 ; Hans Prozesky 4 ; Shobna Sawry 1 ; Karl-Günter Technau 1 ; Alan Davidson 2 ; Cristina Stefan 5 ; Matthias Egger 6 On behalf of IeDEA Southern Africa 1 University of the Witwatersrand, Johannesburg, South Africa; 2 University of Cape Town, Cape Town, South Africa; 3 Red Cross War Memorial Children’s Hospital, Cape Town, South Africa; 4 University of Stellenbosch and Tygerberg Academic Hospital, Cape Town, South Africa; 5 Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa; 6 University of Bern, Bern, Switzerland THURSDAY, FEBRUARY 26, 2015 Session P-O3 Poster Session Poster Hall

Poster Listings

56

CROI 2015